|
1
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Global Burden of Disease Liver Cancer
Collaboration, ; Akinyemiju T, Abera S, Ahmed M, Alam N, Alemayohu
MA, Allen C, Al-Raddadi R, Alvis-Guzman N, Amoako Y, et al: The
burden of primary liver cancer and underlying etiologies from 1990
to 2015 at the global, regional, and national level: Results from
the global burden of disease study 2015. JAMA Oncol. 3:1683–1691.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Shimada K, Sano T, Sakamoto Y and Kosuge
T: A long-term follow-up and management study of hepatocellular
carcinoma patients surviving for 10 years or longer after curative
hepatectomy. Cancer. 104:1939–1947. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Poon RT: Prevention of recurrence after
resection of hepatocellular carcinoma: A daunting challenge.
Hepatology. 54:757–759. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tralhao JG, Dagher I, Lino T, Roudie J and
Franco D: Treatment of tumour recurrence after resection of
hepatocellular carcinoma. Analysis of 97 consecutive patients. Eur
J Surg Oncol. 33:746–751. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Aravalli RN, Steer CJ and Cressman EN:
Molecular mechanisms of hepatocellular carcinoma. Hepatology.
48:2047–2063. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gupta N, Manevich Y, Kazi AS, Tao JQ,
Fisher AB and Bates SR: Identification and characterization of p63
(CKAP4/ERGIC-63/CLIMP-63), a surfactant protein A binding protein,
on type II pneumocytes. Am J Physiol Lung Cell Mol Physiol.
291:L436–L446. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Schweizer A, Ericsson M, Bachi T,
Griffiths G and Hauri HP: Characterization of a novel 63 kDa
membrane protein. Implications for the organization of the
ER-to-Golgi pathway. J Cell Sci. 104:671–683. 1993.PubMed/NCBI
|
|
9
|
Nikonov AV, Hauri HP, Lauring B and
Kreibich G: Climp-63-mediated binding of microtubules to the ER
affects the lateral mobility of translocon complexes. J Cell Sci.
120:2248–2258. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Shibata Y, Shemesh T, Prinz WA, Palazzo
AF, Kozlov MM and Rapoport TA: Mechanisms determining the
morphology of the peripheral ER. Cell. 143:774–788. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Bates SR, Kazi AS, Tao JQ, Yu KJ, Gonder
DS, Feinstein SI and Fisher AB: Role of P63 (CKAP4) in binding of
surfactant protein-A to type II pneumocytes. Am J Physiol Lung Cell
Mol Physiol. 295:L658–L669. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Conrads TP, Tocci GM, Hood BL, Zhang CO,
Guo L, Koch KR, Michejda CJ, Veenstra TD and Keay SK: CKAP4/p63 is
a receptor for the frizzled-8 protein-related antiproliferative
factor from interstitial cystitis patients. J Biol Chem.
281:37836–37843. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shahjee HM, Koch KR, Guo L, Zhang CO and
Keay SK: Antiproliferative factor decreases Akt phosphorylation and
alters gene expression via CKAP4 in T24 bladder carcinoma cells. J
Exp Clin Cancer Res. 29:1602010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kimura H, Fumoto K, Shojima K, Nojima S,
Osugi Y, Tomihara H, Eguchi H, Shintani Y, Endo H, Inoue M, et al:
CKAP4 is a Dickkopf1 receptor and is involved in tumor progression.
J Clin Invest. 126:2689–2705. 2016. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kikuchi A, Fumoto K and Kimura H: The
Dickkopf1-cytoskeleton-associated protein 4 axis creates a novel
signalling pathway and may represent a molecular target for cancer
therapy. Br J Pharmacol. 174:4651–4665. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Shinno N, Kimura H, Sada R, Takiguchi S,
Mori M, Fumoto K, Doki Y and Kikuchi A: Activation of the
Dickkopf1-CKAP4 pathway is associated with poor prognosis of
esophageal cancer and anti-CKAP4 antibody may be a new therapeutic
drug. Oncogene. 37:3471–3484. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Johnston HE, Carter MJ, Larrayoz M, Clarke
J, Garbis SD, Oscier D, Strefford JC, Steele AJ, Walewska R and
Cragg MS: Proteomics profiling of CLL versus healthy B-cells
identifies putative therapeutic targets and a subtype-independent
signature of spliceosome dysregulation. Mol Cell Proteomics.
17:776–791. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Kimura H, Yamamoto H, Harada T, Fumoto K,
Osugi Y, Sada R, Maehara N, Hikita H, Mori S, Eguchi H, et al:
CKAP4, a DKK1 receptor, is a biomarker in exosomes derived from
pancreatic cancer and a molecular target for therapy. Clin Cancer
Res. 25:1936–1947. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Li SX, Tang GS, Zhou DX, Pan YF, Tan YX,
Zhang J, Zhang B, Ding ZW, Liu LJ, Jiang TY, et al: Prognostic
significance of cytoskeleton-associated membrane protein 4 and its
palmitoyl acyltransferase DHHC2 in hepatocellular carcinoma.
Cancer. 120:1520–1531. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Li SX, Liu LJ, Dong LW, Shi HG, Pan YF,
Tan YX, Zhang J, Zhang B, Ding ZW, Jiang TY, et al: CKAP4 inhibited
growth and metastasis of hepatocellular carcinoma through
regulating EGFR signaling. Tumour Biol. 35:7999–8005. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Wang Y, Yu W, He M, Huang Y, Wang M and
Zhu J: Serum cytoskeleton-associated protein 4 as a biomarker for
the diagnosis of hepatocellular carcinoma. Onco Targets Ther.
12:359–364. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Cao Y, Ding W, Zhang J, Gao Q, Yang H, Cao
W, Wang Z, Fang L and Du R: Significant down-regulation of urea
cycle generates clinically relevant proteomic signature in
hepatocellular carcinoma patients with macrovascular invasion. J
Proteome Res. 18:2032–2044. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ramalho FS, Ramalho LN, Della Porta L and
Zucoloto S: Comparative immunohistochemical expression of p63 in
human cholangiocarcinoma and hepatocellular carcinoma. J
Gastroenterol Hepatol. 21:1276–1280. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Grinchuk OV, Yenamandra SP, Iyer R, Singh
M, Lee HK, Lim KH, Chow PK and Kuznetsov VA: Tumor-adjacent tissue
co-expression profile analysis reveals pro-oncogenic ribosomal gene
signature for prognosis of resectable hepatocellular carcinoma. Mol
Oncol. 12:89–113. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang H, Huo X, Yang XR, He J, Cheng L,
Wang N, Deng X, Jin H, Wang N, Wang C, et al: STAT3-mediated
upregulation of lncRNA HOXD-AS1 as a ceRNA facilitates liver cancer
metastasis by regulating SOX4. Mol Cancer. 16:1362017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mah WC, Thurnherr T, Chow PK, Chung AY,
Ooi LL, Toh HC, The BT, Saunthararajah Y and Lee CG: Methylation
profiles reveal distinct subgroup of hepatocellular carcinoma
patients with poor prognosis. PLoS One. 9:e1041582014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Li MH, Dong LW, Li SX, Tang GS, Pan YF,
Zhang J, Wang H, Zhou HB, Tan YX, Hu HP and Wang HY: Expression of
cytoskeleton-associated protein 4 is related to lymphatic
metastasis and indicates prognosis of intrahepatic
cholangiocarcinoma patients after surgery resection. Cancer Lett.
337:248–253. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Desert R, Mebarki S, Desille M, Sicard M,
Lavergne E, Renaud S, Bergeat D, Sulpice L, Perret C, Turlin B, et
al: ‘Fibrous nests’ in human hepatocellular carcinoma express a
Wnt-induced gene signature associated with poor clinical outcome.
Int J Biochem Cell Biol. 81:195–207. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Huang Y, Yang X, Zhao F, Shen Q, Wang Z,
Lv X, Hu B, Yu B, Fan J and Qin W: Overexpression of Dickkopf-1
predicts poor prognosis for patients with hepatocellular carcinoma
after orthotopic liver transplantation by promoting cancer
metastasis and recurrence. Med Oncol. 31:9662014. View Article : Google Scholar : PubMed/NCBI
|
